identif
autoantibodi
cours
diseas
shown
use
make
diagnosi
understand
mechan
pathogenesi
identifi
therapeut
strategi
monitor
treatment
numer
exampl
util
autoantibodi
detect
seen
system
organspecif
diseas
topic
immunemedi
vision
loss
emphasi
autoimmun
reactiv
autoimmun
diseas
eye
rapidli
expand
area
research
therapi
mainten
selftoler
within
retina
may
overcom
combin
factor
includ
genet
environment
factor
review
highlight
retinopathi
associ
presenc
antiretin
antibodi
stress
infer
antiretin
antibodi
describ
review
actual
induc
ocular
diseas
rather
wish
highlight
concept
one
may
util
sera
identifi
immun
reactiv
posterior
segment
eye
detect
autoantibodi
may
allow
one
subtyp
diseas
accord
autoantibodi
profil
process
may
help
defin
specif
subgroup
retinopathi
term
pathogenesi
therapi
immunemedi
retin
damag
may
result
combin
factor
antibodi
activ
cell
macrophag
cytokin
product
fact
cytokin
chemokin
adhes
molecul
produc
infiltr
ocular
resid
cell
may
contribut
significantli
ocular
tissu
damag
varieti
human
experiment
retinopathi
associ
product
antiretin
antibodi
shown
tabl
retinopathi
categor
three
group
visual
paraneoplast
disord
frequent
refer
cancerassoci
retinopathi
car
ii
infectionassoci
retinopathi
iii
retin
degen
disord
visual
paraneoplast
disord
observ
sever
malign
tabl
car
syndrom
retin
paraneoplast
disord
commonli
associ
smallcel
carcinoma
lung
melanomaassoci
retinopathi
mar
occur
patient
cutan
melanoma
car
car
commonli
associ
smallcel
carcinoma
lung
also
less
frequent
report
patient
breast
endometri
cancer
patient
antibodi
develop
reactiv
retina
respons
associ
rod
cone
dysfunct
visual
loss
occur
month
may
even
preced
identif
malign
associ
progress
blind
remot
effect
cancer
first
report
subsequ
studi
shown
autoimmun
mechan
cancerinduc
blind
may
oper
sinc
patient
antiretin
antiphotoreceptor
cell
antibodi
respond
corticosteroid
past
two
decad
thirkil
keltner
forefront
identifi
antiretin
antibodi
car
j
l
keltner
c
e
thirkil
editori
j
ophthalmol
erratum
analysi
autoantibodi
immunofluoresc
antibodi
fa
assay
use
retin
section
demonstr
reactiv
photoreceptor
outer
segment
ganglion
cell
retina
analysi
retin
antigen
reveal
varieti
antigen
may
involv
process
primari
antigen
identifi
antigen
recoverin
retin
enolas
kda
group
reactiv
retin
antigen
identifi
molecul
recent
studi
identifi
tubbylik
protein
autoantigen
car
although
retin
antigen
describ
car
syndrom
common
antigen
link
car
recoverin
calciumbind
protein
found
rod
cone
identif
antiretin
reactiv
car
syndrom
import
term
therapi
abil
monitor
diseas
progress
treatment
car
syndrom
includ
anticanc
therapi
prednison
plasmapheresi
intraven
immunoglobulin
point
spontan
recoveri
vision
diseas
report
instanc
administr
steroid
antilymphocyt
serum
result
improv
visual
function
review
literatur
shown
follow
corticosteroid
treatment
patient
recov
visual
function
gener
believ
immunosuppress
treatment
begun
earli
cours
degen
process
visual
improv
stabil
may
achiev
howev
therapi
like
benefici
widespread
retin
degener
occur
keltner
thirkil
editori
antiretin
antibodi
initi
identifi
immunofluoresc
assay
retin
tissu
follow
confirmatori
assay
western
blot
enzymelink
immunosorb
assay
monitor
level
antiretin
antibodi
immunosuppress
therapi
test
least
five
case
report
demonstr
decreas
antiretin
autoantibodi
patient
car
recov
visual
function
follow
variou
form
immunosuppress
treatment
clearli
addit
studi
need
care
evalu
fluctuat
antibodi
titer
cours
diseas
treatment
multicent
studi
initi
share
sera
clinic
inform
order
determin
antibodi
profil
use
marker
start
continu
discontinu
treatment
car
syndrom
probabl
extens
studi
blind
diseas
associ
antiretin
antibodi
common
antigen
recoverin
report
malign
cell
smallcel
carcinoma
induc
express
recoverin
mcginni
et
al
suggest
mutat
event
inactiv
tumor
suppressor
gene
may
turn
synthesi
recoverin
protein
antibodi
reactiv
recoverin
may
result
blockag
ion
channel
cellular
depolar
event
may
lead
photoreceptor
cell
death
possibl
mechan
involv
antirecoverin
antibodyinduc
photoreceptor
cell
death
examin
three
recent
report
vitro
studi
demonstr
antirecoverin
antibodi
enter
photoreceptor
cell
trigger
apoptosi
antirecoverin
antibodi
inocul
rat
intravitr
rout
apoptosi
photoreceptor
bipolar
cell
observ
vitro
vivo
studi
demonstr
antirecoverin
antibodi
trigger
apoptosi
recoverinposit
cell
studi
suggest
antibodymedi
degener
photoreceptor
occur
apoptot
mechan
second
paraneoplast
syndrom
identifi
mar
occur
patient
cutan
melanoma
progress
visual
loss
develop
month
frequent
associ
metastat
melanoma
electroretinogram
erg
patient
character
reduct
photop
bwave
scotop
bwave
erg
chang
correspond
function
defect
retin
onpathway
respons
involv
depolar
bipolar
cell
patient
mar
develop
antibodi
reactiv
recoverin
seen
car
syndrom
antibodi
mar
patient
react
bipolar
cell
dendrit
outer
plexiform
layer
retina
recent
work
lei
et
al
demonstr
intravitr
inject
mar
immunoglobulin
g
monkey
eye
result
alter
monkey
erg
pattern
consist
chang
observ
bipolar
cell
clinic
experiment
observ
car
mar
probabl
provid
best
evid
patholog
role
selfreact
antibodi
human
retinopathi
first
car
mar
patient
suffer
retinopathi
character
retin
tissu
damag
presenc
antiretin
antibodi
second
patient
respond
plasma
exchang
immunosuppress
therapi
third
retin
cell
damag
induc
selfreact
antibodi
vitro
evid
passiv
transfer
diseas
anim
second
group
retinopathi
associ
antiretin
antibodi
retin
disord
trigger
infecti
agent
numer
studi
bodi
site
clearli
identifi
link
infect
autoimmun
autoimmun
diseas
limit
number
studi
retin
disord
perform
highlight
two
human
diseas
trigger
onchocerca
volvulu
toxoplasma
gondii
experiment
model
refer
experiment
coronaviru
retinopathi
ecor
trigger
murin
coronaviru
mous
hepat
viru
mhv
tabl
onchocerciasi
infect
nematod
parasit
volvulu
result
sever
eye
diseas
often
refer
river
blind
estim
approxim
million
peopl
africa
central
south
america
infect
organ
approxim
one
million
blind
sever
visual
impair
ocular
diseas
occur
anterior
segment
eye
consist
corneal
opacif
scleros
kerat
wherea
ocular
diseas
occur
posterior
pole
character
retin
degener
gener
believ
ocular
patholog
result
hostdirect
inflammatori
respons
nematod
posterior
ocular
onchocerciasi
character
atrophi
retin
pigment
epithelium
rpe
lesion
advanc
subretin
fibrosi
occur
number
studi
indic
retin
diseas
process
may
involv
autoimmun
respons
chan
et
al
found
major
onchocerciasi
patient
antiretin
antibodi
sera
vitreou
use
fa
assay
human
retin
tissu
chan
et
al
observ
reactiv
inner
retina
photoreceptor
layer
braun
associ
perform
number
studi
elucid
natur
autoimmun
reactiv
author
identifi
recombin
antigen
volvulu
show
immunolog
crossreact
compon
rpe
western
blot
analysi
antibodi
mw
antigen
volvulu
recogn
compon
rpe
cell
subsequ
studi
shown
antigen
present
optic
nerv
epitheli
layer
iri
ciliari
bodi
rpe
although
protein
homologu
show
limit
amino
acid
sequenc
ident
immun
rat
either
volvulu
human
retin
tissu
induc
ocular
patholog
activ
retin
microglia
also
associ
extens
breakdown
posterior
bloodocular
barrier
studi
indic
molecular
mimicri
volvulu
human
rpe
protein
may
contribut
retinopathi
found
patient
onchocerciasi
toxoplasmosi
estim
protozoan
parasit
gondii
infect
million
human
worldwid
gondii
also
frequent
identifi
etiolog
agent
posterior
uveiti
toxoplasma
retinochoroid
import
caus
blind
young
adult
histor
ocular
manifest
thought
result
congenit
infect
howev
recent
evid
accumul
past
year
indic
infect
via
ingest
parasit
contamin
soil
meat
may
also
result
ocular
diseas
patient
toxoplasma
retinochoroid
gondii
cyst
identifi
within
retina
rpe
cell
sever
mechan
retin
tissu
damag
identifi
includ
direct
parasiteinduc
cell
lysi
product
parasit
toxin
immunopatholog
reactiv
parasit
number
report
identifi
antiretin
anti
antigen
reactiv
gondiiinfect
individu
recent
studi
identifi
antiretin
antibodi
also
gener
patient
toxoplasma
retinochorid
use
fa
analysi
human
retin
tissu
section
whittl
et
al
identifi
antiretin
antibodi
patient
toxoplasma
retinochorid
antibodi
direct
photoreceptor
studi
screen
dilut
identifi
posit
reaction
toxoplasma
retinochoroid
patient
contrast
normal
subject
idiopath
uveiti
patient
posit
feel
screen
dilut
probabl
inappropri
low
fortun
sera
also
test
higher
dilut
dilut
antiphotoreceptor
antibodi
detect
toxoplasma
retino
choroid
patient
normal
subject
uveiti
patient
twentyf
percent
toxoplasma
retino
choroid
patient
show
posit
reactiv
dilut
taken
togeth
report
suggest
high
preval
antiretin
antibodi
direct
photoreceptor
layer
gondiiinfect
patient
evid
antibodi
act
alon
induc
retin
tissu
damag
howev
know
vitro
studi
gondii
infect
human
rpe
cell
result
upregul
varieti
cytokin
granulocytemacrophag
colonystimul
factor
adhes
molecul
produc
gondii
replic
human
rpe
suggest
rose
cytokin
profil
initi
infect
may
drive
progress
benign
autoimmun
pathogen
autoimmun
diseas
experiment
coronaviru
retinopathi
murin
coronaviru
mhv
natur
occur
hepat
viru
neurotrop
strain
identifi
ocular
infect
suscept
mous
strain
lead
biphas
diseas
first
manifest
acut
retin
inflamm
follow
chronic
immuneassoci
retin
degener
degen
phase
diseas
viru
nucleic
acid
persist
within
retina
howev
infecti
viru
found
target
cell
earli
infect
rpe
cell
ciliari
bodi
epitheli
cell
mullerlik
cell
photoreceptor
role
immun
system
degen
phase
support
identif
antiretin
antirp
cell
antibodi
retin
degenerationsuscept
mice
autoantibodi
absent
retin
degener
resist
mice
demonstr
acut
phase
diseas
present
evalu
retin
rpe
cell
epitop
identifi
ecor
viru
infect
man
frequent
associ
develop
autoimmun
reactiv
ecor
anim
model
system
establish
delin
possibl
mechan
oper
virustrigg
retin
degener
thu
ecor
provid
model
suggest
human
retin
degen
diseas
genet
predisposit
autoimmun
compon
may
trigger
virus
thousand
human
diagnos
retin
degener
howev
abil
determin
viral
trigger
hamper
difficulti
obtain
ocular
sampl
initi
stage
diseas
altern
approach
may
consist
correl
studi
determin
certain
retin
degen
process
associ
specif
antiretin
antibodi
may
viral
etiolog
third
group
retinopathi
associ
antiretin
antibodi
classifi
retin
degen
disord
tabl
subdivid
disord
five
class
retin
pigmentosa
rp
cystoid
macular
edema
recoverinassoci
retinopathi
rar
agerel
macular
degener
idiopath
retinopathi
retinopathi
associ
autoimmun
neurolog
diseas
rp
rp
consid
hereditari
degen
process
often
lead
blind
howev
patient
famili
histori
retin
degener
screen
patient
sera
fa
assay
human
retin
tissu
shown
approxim
patient
antiretin
antibodi
galbraith
et
al
show
antiretin
antibodi
direct
neurofila
protein
moreov
rpe
cell
within
retina
patient
upregul
express
major
histocompat
complex
class
ii
molecul
patient
rp
shown
breakdown
retinalblood
barrier
difficult
associ
develop
antiretin
antibodi
specif
retin
tissu
damag
recent
heckenl
et
al
attempt
identifi
subpopul
rp
patient
determin
antiretin
antibodi
associ
select
diseas
process
fortifi
knowledg
macular
edema
seen
car
investig
initi
prospect
studi
evalu
antiretin
antibodi
patient
bilater
cystoid
edema
cyst
panretin
degener
found
signific
associ
cystoid
macular
edema
antiretin
antibodi
rp
patient
nineti
percent
rp
patient
macular
edema
contain
antiretin
antibodi
sera
contrast
rp
patient
without
macular
edema
normal
subject
antiretin
antibodi
reactiv
common
retin
protein
carbon
anhydras
ii
kda
enolas
kda
recoverinassoci
retinopathi
recent
whitcup
et
al
propos
use
term
recoverinassoci
retinopathi
describ
condit
patient
clinic
immunolog
diseas
similar
car
without
detect
underli
malign
investig
describ
patient
rapidli
progress
loss
vision
retin
degener
extinguish
erg
moreov
patient
elev
level
antibodi
serum
recoverin
display
strong
cellular
immun
respons
recoverin
thu
clinic
electrophysiolog
immunolog
data
present
despit
absenc
underli
malign
antirecoverin
antibodi
also
identifi
patient
clinic
find
consist
rp
studi
indic
recoverinassoci
retinopathi
absenc
cancer
may
widespread
phenomena
previous
recogn
armd
agerel
macular
degener
armd
common
caus
blind
unit
state
yet
etiolog
diseas
still
defin
gurn
et
al
studi
antiretin
autoimmun
one
pathogenet
factor
patient
diseas
sera
patient
demonstr
posit
bind
predominantli
doublet
protein
kda
serum
antibodi
also
react
protein
isol
photoreceptor
outer
segment
human
bovin
monkey
origin
crossreact
serum
antibodi
protein
kda
lower
band
present
bovin
purifi
protein
prepar
suggest
protein
may
compon
neuron
cytoskeleton
unclear
whether
autoantibodi
play
direct
role
etiolog
armd
simpli
repres
respons
retin
damag
idiopath
retinopathi
varieti
idiopath
retinopathi
retin
degen
diseas
associ
presenc
antiretin
antibodi
exampl
whittl
et
al
demonstr
antibodi
photoreceptor
layer
outer
plexiform
layer
detect
frequent
patient
retin
vascul
patient
system
vascul
antiretin
muller
cellspecif
autoantibodi
also
describ
patient
progress
loss
vision
chan
et
al
found
antiretin
reactiv
photoreceptor
muller
cell
vogtkoyanagiharada
syndrom
presenc
antibodi
correl
diseas
activ
also
possibl
antiretin
antibodi
play
role
retin
white
dot
syndrom
extens
evalu
develop
antiretin
antibodi
need
diseas
clear
antibodi
preced
retin
diseas
immun
reactiv
consequ
retin
degen
process
either
case
autoantibodi
may
contribut
diseas
process
ideal
studi
character
autoreact
may
allow
subclassif
retinopathi
analysi
may
instrument
design
treatment
strategi
number
retin
antigen
evalu
implic
uveiti
antigen
irbp
two
antigen
retin
antigen
appear
play
role
tcellmedi
diseas
process
within
eye
beyond
neurolog
diseas
associ
retinopathi
final
recent
studi
identifi
neurolog
diseas
may
also
present
immunemedi
retinopathi
concept
pathogenet
role
autoantibodi
neurolog
diseas
recent
review
stiffman
syndrom
rare
neurolog
disord
character
rigid
axial
proxim
limb
muscl
autoimmun
pathogenesi
suggest
due
presenc
autoantibodi
direct
glutam
acid
decarboxylas
gad
patient
recent
steffen
et
al
identifi
patient
stiffman
syndrom
develop
sever
bilater
visual
deterior
patient
sera
contain
antigad
antibodi
react
gabaerg
retin
structur
suggest
reactiv
may
associ
ophthalm
manifest
review
highlight
fact
patient
retin
degen
diseas
develop
antiretin
autoantibodi
howev
antibodi
direct
varieti
differ
antigen
date
insuffici
data
accur
identifi
specif
sensit
assay
system
obviou
standard
antiretin
reactiv
critic
research
studi
develop
diagnost
assay
system
futur
import
establish
dialog
encourag
exchang
serum
among
investig
standard
antiretin
autoantibodi
addit
advantag
develop
profici
test
program
monitor
assay
perform
differ
laboratori
pathogenet
involv
antibodi
cellular
immun
retin
protein
human
clear
brief
review
present
evid
select
retinopathi
associ
develop
antiretin
antibodi
initi
factor
contribut
gener
autoantibodi
may
vari
differ
clinicopatholog
set
car
antibodi
direct
tumorinduc
antigen
also
recogn
protein
within
retina
infectionassoci
retinopathi
antibodi
direct
infecti
agent
may
crossreact
retin
protein
antibodi
react
retin
antigen
releas
infect
retin
degen
diseas
antibodi
identifi
react
varieti
retin
antigen
diseas
difficult
determin
antiretin
antibodi
initi
diseas
process
retin
degener
occur
first
immun
respons
later
trigger
select
releas
retin
antigen
irrespect
initi
event
presenc
antiretin
antibodi
may
contribut
patholog
process
involv
select
retinopathi
present
identif
antiretin
antibodi
neither
specif
sensit
diagnosi
retinopathi
nevertheless
demonstr
antibodi
may
help
diagnost
prognost
marker
patient
retin
diseas
analysi
immunemedi
vision
loss
infanc
care
analysi
character
antiretin
antibodi
specifici
help
understand
mechan
diagnosi
patient
form
vision
loss
